Dr. Joshua Seth Bernstein, MD

Dr. Bernstein practices at University of Cincinnati Physicians Company in Cincinnati, Ohio.

Dr. Bernstein's NPI, 1174014955, was assigned on May 29, 2018. Dr. Bernstein graduated from University of Cincinnati College of Medicine in 2018. Dr. Bernstein holds Ohio license 35.148817.

Dr. Bernstein's primary practice is University of Cincinnati Physicians Company, at 3590 Lucille Dr, Cincinnati, OH 45213 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Bernstein's primary practice is University of Cincinnati Physicians Company in Cincinnati, Ohio. Dr. Bernstein is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Bernstein to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Bernstein's licenses on file in 3 states: Ohio, Colorado and Illinois.

CMS data shows 48 Medicare services from Dr. Bernstein across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $3,005 for them. Every service was in an office.

CMS counts 39 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 65 to 74, with 24 patients. 69% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 44, with 73% women.

In 2024, Dr. Bernstein wrote 152 Medicare Part D claims for 41 patients. 74% of them were for generic drugs. CMS names the drug for 91 of them, across 3 drugs with 11 or more claims each, at $2,380 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Bernstein for performance year 2024, reported as part of a group. Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Bernstein, published from 2020 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Chronic Urticaria and Rhinitis. Dr. Bernstein has published most often in Ann Allergy Asthma Immunol. Dr. Bernstein's most frequent co-authors are Jonathan Bernstein, MD, Jonathan A. Bernstein, MD and Bruce Devon Ball, MD.

CMS Open Payments shows 24 general payments to Dr. Bernstein from 11 drug and device companies from 2020 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 56% of the total. GlaxoSmithKline, LLC. paid the most, $10,112.

Dr. Bernstein graduated from University of Cincinnati College of Medicine in 2018.